US medical device maker Greatbatch Inc. today announced that it will establish an Active Implantable Medical Device (AIMD) Research and Development Center in Singapore. The establishment of this multinational R&D centre is a continuation of the firm’s medical device strategy and the first step of its Asia Pacific strategy to engage in emerging healthcare markets. Greatbatch’s latest venture in Singapore is a significant development for the country’s biomedical sector – it is the first R&D centre for active implantable medical devices in Singapore and in Asia.
The Greatbatch Singapore AIMD R&D Center will immediately focus on the design and development of active implantable medical devices to serve the cardiovascular and neuromodulation markets. Both are multibillion dollar markets with considerable long-term growth potential.Yvonne Klöpping